Status:
COMPLETED
Utility of High Flow Nasal Cannula in CO Toxicity
Lead Sponsor:
Kocaeli University
Conditions:
Carbon Monoxide Poisoning
Environmental Exposure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
determination of the half-life of COHb in CO-poisoned patients with high flow nasal oxygen therapy in the ED.
Detailed Description
Carbon monoxide (CO) poisoning is common and potentially fatal environmental emergency which requires immediate attention. It is responsible for up to 40,000 emergency department (ED) visits and 5000 ...
Eligibility Criteria
Inclusion
- The patients who are admitted to the emergency department with CO poisoning with a CoHB level of \>10%.
- The patients who accept to participate in the study.
Exclusion
- The patients who are \<18 years old.
- The patients who need mechanical ventilation
- The patients who are implemented oxygen more than 30 minutes before the ED admission
- The patients who will be transferred to the hyperbaric oxygen center before the CoHB levels are decreased to the half.
Key Trial Info
Start Date :
March 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 6 2018
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03342209
Start Date
March 1 2017
End Date
February 6 2018
Last Update
April 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kocaeli University Medical Faculty
Kocaeli, Izmit, Turkey (Türkiye), 41300